227 related articles for article (PubMed ID: 23783642)
1. Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
Holder AA; Taylor P; Magnusen AR; Moffett ET; Meyer K; Hong Y; Ramsdale SE; Gordon M; Stubbs J; Seymour LA; Acharya D; Weber RT; Smith PF; Dismukes GC; Ji P; Menocal L; Bai F; Williams JL; Cropek DM; Jarrett WL
Dalton Trans; 2013 Sep; 42(33):11881-99. PubMed ID: 23783642
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and preliminary
Lewis NA; Liu F; Seymour L; Magnusen A; Erves TR; Arca JF; Beckford FA; Venkatraman R; González-Sarrías A; Fronczek FR; Vanderveer DG; Seeram NP; Liu A; Jarrett WL; Holder AA
Eur J Inorg Chem; 2012 Feb; 2012(4):664-677. PubMed ID: 23904789
[TBL] [Abstract][Full Text] [Related]
3. A novel ruthenium(II)-cobaloxime supramolecular complex for photocatalytic H2 evolution: synthesis, characterisation and mechanistic studies.
Cropek DM; Metz A; Müller AM; Gray HB; Horne T; Horton DC; Poluektov O; Tiede DM; Weber RT; Jarrett WL; Phillips JD; Holder AA
Dalton Trans; 2012 Nov; 41(42):13060-73. PubMed ID: 23001132
[TBL] [Abstract][Full Text] [Related]
4. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
5. Mixed ligand ruthenium(II) complexes of bis(pyrid-2-yl)-/bis(benzimidazol-2-yl)-dithioether and diimines: study of non-covalent DNA binding and cytotoxicity.
Rajendiran V; Murali M; Suresh E; Sinha S; Somasundaram K; Palaniandavar M
Dalton Trans; 2008 Jan; (1):148-63. PubMed ID: 18399241
[TBL] [Abstract][Full Text] [Related]
6. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
7. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, DNA binding studies, photocleavage, cytotoxicity and docking studies of ruthenium(II) light switch complexes.
Gabra NM; Mustafa B; Kumar YP; Devi CS; Srishailam A; Reddy PV; Reddy KL; Satyanarayana S
J Fluoresc; 2014 Jan; 24(1):169-81. PubMed ID: 23982735
[TBL] [Abstract][Full Text] [Related]
9. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F
Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium porphyrin compounds for photodynamic therapy of cancer.
Schmitt F; Govindaswamy P; Süss-Fink G; Ang WH; Dyson PJ; Juillerat-Jeanneret L; Therrien B
J Med Chem; 2008 Mar; 51(6):1811-6. PubMed ID: 18298056
[TBL] [Abstract][Full Text] [Related]
12. An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.
Zhao X; Li M; Sun W; Fan J; Du J; Peng X
Chem Commun (Camb); 2018 Jun; 54(51):7038-7041. PubMed ID: 29873358
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
15. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
Sangeetha S; Murali M
Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
[TBL] [Abstract][Full Text] [Related]
20. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]